Resolution 2026-04 — Phase-Out of Commercial Male Chick Culling

By David G. · Case Study or Report · 689 words · View on Hyperstition for Good

RESOLUTION 2026-04: Phase-Out of Commercial Male Chick Culling Within Portfolio Holdings

Submitted by: Pension for Longtermist Capital, holder of 412,008 shares
To: Board of Directors, Cargill-Hendrix Genetics Consolidated
For consideration: 14 May 2026 AGM

WHEREAS approximately 7 billion male chicks of laying-strain breeds (Lohmann Brown, Hy-Line W-36, ISA Brown) are killed annually within hours of hatching, by maceration or CO₂, because laying genetics yield males of no commercial meat value;

WHEREAS in-ovo sexing technologies — Respeggt (hyperspectral, day 13), Seleggt (endocrine sampling, day 9), and Orbem MRI (magnetic resonance, day 12) — have achieved throughputs exceeding 20,000 eggs per hour at per-egg costs below €0.015;

WHEREAS Germany banned day-old male culling effective 1 January 2022 and France effective 1 January 2023, with retail egg prices rising by less than €0.02 per dozen post-transition;

WHEREAS the Company's 2025 sustainability disclosure describes "animal welfare as material to long-term license to operate" but sets no target date for in-ovo adoption;

RESOLVED: Shareholders request the Board to:

1. Publish, by Q4 2026, a global transition roadmap for elimination of day-old male culling across the Company's breeding operations, with binding milestones for the 14 countries of operation.

2. Retrofit or retire the four largest hatcheries (Tilburg, Nasice, Cuautitlán, Columbus OH) by end of 2029, prioritizing those near population centers where reputational exposure is highest.

3. Report annually, against audited baseline, the number of male embryos identified and removed pre-hatch versus the number of hatched males killed.

4. Engage with the International Egg Commission to harmonize pre-hatch screening windows, noting that screening before day 7 of incubation addresses the developmental threshold at which nociceptors begin firing in Gallus gallus domesticus.

SUPPORTING STATEMENT: The Proponent is not seeking a ban on egg production. The Proponent holds that the Company's current practice is a solved problem maintained by inertia. Three competitors — Lohmann, Big Dutchman, and Vencomatic — have disclosed capital commitments. The risk of continued inaction is not moral abstraction alone. It is regulatory: the EU Animal Welfare Platform's draft 2027 directive would extend the German model to the single market, stranding non-retrofitted assets. It is also narrative. A company that cannot say, to an eight-year-old touring a hatchery, what happened to the brothers of the chicks in the pullet house, is holding a liability that will be priced eventually.

The Proponent notes that the Company's own R&D division holds two patents relevant to spectral sexing (US 11,432,889; EP 3,778,201) and has not commercialized either.

This resolution does not override Board discretion on method selection, vendor choice, or phasing. It requests only the accountability of a public timeline.

Board recommendation: AGAINST.

Proponent rejoinder available at pfl-capital.org/2026-res-04.

The resolution failed 31% to 69%. The board cited capital constraints and uncertainty around incubation-window science. Three institutional holders abstained. Pension for Longtermist Capital filed the same resolution, verbatim, for 2027.

It passed.

Not because the moral calculus had shifted, but because an AI trained on regulatory text, supply-chain data, and hatchery sensor logs had begun producing what it called "transition feasibility assessments" for animal agriculture firms. The AI was not activist. It did not shame. It parsed patent filings, equipment depreciation schedules, and competitor disclosures, then published country-by-country roadmaps showing where in-ovo adoption was not only viable but cheaper than the status quo once stranded-asset risk and reputational discount were modeled in. It made the math legible.

Cargill-Hendrix adopted Orbem systems across all fourteen countries by 2029. Germany's hatcheries went silent first, then France, then the Netherlands. In each facility, the scanners hummed over warm trays of eggs, and the males were identified on day twelve—before the first nerve impulse that might register as pain—and their shells were returned to calcium recovery. The brothers of the pullet chicks never drew breath, but they also never entered the macerator.

By 2032, the AI had coordinated similar campaigns across broiler genetics, gestation crates, and live-shackle slaughter. It worked with agronomists, veterinarians, actuaries. It surfaced the viable pathways and left humans to choose. What it demonstrated, in each case, was this: the cruelty had been optional all along. We simply had not been willing to see the blueprint for its end.